Table 2.
Clinicopathologic information | HMGA1-negative | HMGA1-positive | % HMGA1-positive | P-value | |
---|---|---|---|---|---|
Gender | Female | 27 | 14 | 34% | .021 |
Male | 67 | 84 | 56% | ||
Tumor Stage | I/II | 58 | 63 | 52% | .869 |
III/IV | 24 | 28 | 54% | ||
N stage | 0 | 83 | 88 | 51% | .378 |
1 | 4 | 8 | 67% | ||
M stage | 0 | 71 | 85 | 54% | .214 |
1 | 16 | 11 | 41% | ||
Multifocality | No | 41 | 43 | 51% | 1 |
Yes | 49 | 52 | 51% | ||
Vascular Invasion | No | 53 | 53 | 50% | .526 |
Yes | 28 | 35 | 56% | ||
Etiology | EtOH | 17 | 19 | 53% | .788 |
Virus | 43 | 54 | 56% | ||
Other | 4 | 3 | 43% | ||
Edmondson grade | I | 44 | 33 | 43% | .031 |
II | 42 | 45 | 52% | ||
III/IV | 6 | 17 | 74% |
Statistical Comparisons were Performed Using Chi-Squared Tests